Profiling BRCA1-BRCT interactions and their functional relevance at amino acid resolution
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Venda Mangkusaputra und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Leiden University Medical Center (LUMC), Einthovenweg 20, 2333 ZC Leiden, The Netherlands. Hauptthemen laut MEDLINE: BRCA1 Protein, Carrier Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Research Council, NWO-VIDI, Oncode.
Abstract (Originalsprache)
BRCA1 (breast cancer-associated protein 1) plays a central role in homologous recombination (HR) through interactions with multiple proteins across its various domains. The C-terminal BRCT domains bind HR regulators such as ABRAXAS1, CtIP, and BRIP1, each contributing to distinct, sometimes opposing, functions. While pathogenic mutations frequently cluster within the canonical BRCT phospho-binding pocket, the broader mutational landscape and its functional consequences remain poorly understood. Here, we used a site-saturation mutagenesis library of the BRCT domains to test >4,000 single-residue variants for their ability to bind ABRAXAS1 and CtIP. Using a yeast two-hybrid screen, we systematically assessed these interactions and validated key findings in mammalian cells. The resulting interaction map identified previously uncharacterized residues critical for partner binding and demonstrated their detrimental impact on HR. Importantly, we identified separation-of-function mutations that selectively disrupt individual protein interactions, enabling a more detailed analysis of each partner’s contribution to HR. Functional assays suggested that disruption of CtIP binding had the most pronounced impact on HR. Furthermore, integration of our data with clinical variant data revealed a strong correlation between loss of protein binding and pathogenicity, highlighting the potential utility of our interaction map for clinical variant interpretation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Leiden University Medical Center (LUMC), Einthovenweg 20, 2333 ZC Leiden, The Netherlands.
- Oncode Institute, Jaarbeursplein 6, 3521 AL Utrecht, The Netherlands.
- Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
- Leiden Genome Technology Center, LUMC, Einthovenweg 20, 2333 ZC Leiden, The Netherlands.
ORCID-Profile: Venda Mangkusaputra, Andrea G Murachelli, Zhengzhou Yu, Annouche den Hollander, Roberta Menafra, Anne Schreuder, Susan L Kloet, Titia K Sixma, Sylvie M Noordermeer
Förderung
- Dutch Research Council
- NWO-VIDI
- Oncode
Zitieren
APA
Mangkusaputra, V., Murachelli, A. G., Yu, Z., Hollander, A. D., Menafra, R., Schreuder, A., Kloet, S. L., Sixma, T. K., & Noordermeer, S. M. (2025). Profiling BRCA1-BRCT interactions and their functional relevance at amino acid resolution. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf848
Vancouver
Mangkusaputra V, Murachelli AG, Yu Z, Hollander AD, Menafra R, Schreuder A, et al. Profiling BRCA1-BRCT interactions and their functional relevance at amino acid resolution. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf848
BibTeX
@article{Mangkusaputra2025,
author = {Mangkusaputra, Venda and Murachelli, Andrea G and Yu, Zhengzhou and Hollander, Annouche den and Menafra, Roberta and Schreuder, Anne and Kloet, Susan L and Sixma, Titia K and Noordermeer, Sylvie M},
title = {Profiling BRCA1-BRCT interactions and their functional relevance at amino acid resolution},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf848}
}
EUVIMED